Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials

Authors: Jessica L. Mega, Nathan O. Stitziel, J. G. Smith, Daniel I. Chasman, Mark J. Caulfield, James J. Devlin, Francesco Nordio, Craig Hyde, Christopher P. Cannon, Frank M. Sacks, Neil R Poulter, Peter Sever, Paul M. Ridker, Eugene Braunwald, Olle Melander, Sekar Kathiresan, Marc S. Sabatine - The Lancet 2015 cited by 707